Investing Profile

Jorge Conde

VCInvestor
General Partner at Andreessen Horowitz
a16z.com/author/jorge-conde/Menlo Park, California
Photo of Jorge Conde, General Partner at Andreessen Horowitz
Your Intro Paths to Jorge Conde

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Jorge is a member of
NewCo Network
1585 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
Harvard Business School Network
506 CONNECTIONS
Self-Employed Network
425 CONNECTIONS
Massachusetts Institute of Technology Network
248 CONNECTIONS

Find Jorge Conde on

cb
Current Investing Position
Andreessen Horowitz General Partner
Investment Range
$1M - $100.0M
Sweet Spot
$10.0M
Investments On Record
20
Current Fund Size
$2.2B

Jorge Conde is on these Sector & Stage Rankings

Jorge Conde's Investments On Record (15)

CompanyStageDateRound SizeTotal Raised
Third Arc Bio
Series AFeb 2026$52M
$52M
Phylo
SeedFeb 2026$14M
$14M
Tome Biosciences
Series ADec 2023$210M
$210M
Co-investors: Alan Crane (Polaris Partners)
Asimov
Series BJan 2023$180M
$180M
Co-investors: Vijay Pande (Andreessen Horowitz)
Vicinitas Therapeutics
Series AJul 2022$65M
$65M
CAMP4 Therapeutics
Series BJul 2022$100M
Series AJun 2021$45M
Series AMay 2018$30M
$180M
Cartography Biosciences
Series AJul 2022$57M
$57M
Octant Bio
Series BApr 2022$80M
Series AMay 2020$30M
$200M
Co-investors: Katie Haun (Haun Ventures), Ling Wong (Highbury Group), Shawn Dimantha (Angel investor), Lars Fjeldsoe-Nielsen (2xN), Clint Korver (Ulu Ventures), Miriam Rivera (Ulu Ventures)

Jorge Conde's Experience

Biotechnology Investment Banking Morgan StanleyPresent
Life Sciences Summer Associate Flagship VenturesPresent
Independent Consultant Biotechnology and genomics companiesPresent
Marketing & Operations Manager MedImmunePresent
Chief Strategy Officer Syros PharmaceuticalsPresent
General Partner Andreessen HorowitzPresent
Board Member Dyno TherapeuticsPresent
Board Member AsimovPresent
Board Member Earli Inc.Present
Independent Consultant NewCoPresent
Board Member Cartography BiosciencesPresent
Board Member Vicinitas TherapeuticsPresent
Board Member Komodo HealthPresent
Board Member OctantPresent
Board Member EarliPresent
Independent Consultant Self-EmployedPresent
Board Member IDRxPresent
Board Member Tome BiosciencesPresent
Board Member CAMP4 TherapeuticsPresent
Board Member EQRxPresent
Board Member Aria PharmaceuticalsPresent
Board Member Tmunity Therapeutics IncorporatedPresent
Chief Strategy Officer | Chief Financial Officer | Chief Product Officer Syros PharmaceuticalsPresent
Co-Founder and CEO | Board of Directors Knome Inc.Present
Independent Consultant University of Washington Applied Physics LaboratoryPresent
Life Sciences Summer Associate Flagship PioneeringPresent

Jorge Conde's Education

Harvard Business School Master of Business Administration (MBA)
The Johns Hopkins University Bachelor of Arts (BA) Biology
Massachusetts Institute of Technology Master of Science (MS) Biomedical Enterprise Program
Harvard-MIT Division of Health Sciences and Technology (HST) Master of Science (MS) Biomedical Enterprise Program